Client News

Carbios publishes first Sustainability Report and underscores commitment to circularity and environmental responsibilities

ABIVAX TO ATTEND THE J.P. MORGAN 41ST ANNUAL HEALTHCARE CONFERENCE

invIOs to present at Biotech Showcase

Apogenix Enrolls First Patients in Pivotal Phase III Trial for the Treatment of Hospitalized COVID-19 Patients with Asunercept

Spexis announces promising pre-clinical data with balixafortide in combination with various therapies on the market for treating B-cell lymphomas

Carbios hosts world’s first PET Biorecycling Summit with Bertrand Piccard, Initiator and Chairman of the Solar Impulse Foundation, as Keynote Speaker

ONWARD Reports Interim Clinical Outcomes for Implantable ARC Therapy Demonstrating Potential to Improve Blood Pressure Regulation after Spinal Cord Injury

Rentschler implements innovative learning program in collaboration with MassBioEd and WPI

Destiny Pharma: US FDA/CDC workshop highlights the need for new approaches for the prevention of hospital-acquired infections

Destiny Pharma announces finalisation of its Phase 3 development plans for XF-73 Nasal